|
US5591767A
|
|
Liquid reservoir transdermal patch for the administration of ketorolac
|
|
US5492534A
|
|
Controlled release portable pump
|
|
US5490415A
|
|
Diffusion test apparatus and method
|
|
WO9410987A1
|
|
Combined analgesic delivery methods for pain management
|
|
AU5551294A
|
|
Transdermal delivery of the eutomer of a chiral drug
|
|
WO9410986A1
|
|
Transdermal delivery of ketorolac
|
|
US5290240A
|
|
Electrochemical controlled dispensing assembly and method for selective and controlled delivery of a dispensing fluid
|
|
US5318540A
|
|
Controlled release infusion device
|
|
EP0523150A1
|
|
Device and method for enhanced administration of physostigmine
|
|
US5135753A
|
|
Method and therapeutic system for smoking cessation
|
|
NZ237241A
|
|
Method for increasing the storage stability of physostigmine
|
|
US5257987A
|
|
Controlled release osmotic infusion system
|
|
AU5216690A
|
|
Periodontal disease treatment system
|
|
NZ233069A
|
|
Controlled drug delivery system for periodontal pocket comprising a suspension of polymer microparticles
|
|
CA2012665A1
|
|
Periodontal disease treatment system
|
|
US5350581A
|
|
Method for manufacturing transdermal devices
|
|
US4943435A
|
|
Prolonged activity nicotine patch
|
|
US4898582A
|
|
Portable infusion device assembly
|
|
US4919939A
|
|
Periodontal disease treatment system
|
|
US4839174A
|
|
Novel transdermal nicotine patch
|
